| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $202.2M | — | +21.5% |
| Cost of Revenue | $54.4M | — | +39.8% |
| Gross Profit | $147.8M | — | +15.9% |
| R&D Expense | $46.3M | — | +17.2% |
| SG&A Expense | $33.7M | — | -1.8% |
| Operating Income | $3.2M | — | +478.4% |
| Pre-tax Income | -$932K | — | -113.8% |
| Income Tax | $593K | — | -20.0% |
| Net Income | -$1.5M | — | -29.6% |
| EPS (Basic) | -$0.02 | — | +0.0% |
| EPS (Diluted) | -$0.02 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $150.0M | +10.5% | +11.1% |
| Short-term Investments | $56.0M | +8.8% | -13.5% |
| Accounts Receivable | $173.9M | -31.8% | +27.8% |
| Current Assets | $454.0M | -12.6% | +10.2% |
| Total Assets | $623.4M | -9.8% | +5.1% |
| Current Liabilities | $402.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $48.8M | — | +8.6% |
| Capital Expenditures | $188K | — | -71.1% |
| Investing Cash Flow | -$5.3M | — | +78.1% |
| Financing Cash Flow | -$28.8M | — | -422.7% |
| Free Cash Flow | $48.6M | — | +9.8% |
| +21.9% |
| Long-term Debt | $238.4M | -1.0% | -3.9% |
| Total Liabilities | $682.3M | -7.6% | +9.2% |
| Stockholders' Equity | -$59.0M | -25.5% | -85.8% |